Navigation Links
SEK100 million ($12.83 million) for Karolinska Institutet's research into regenerative medicine
Date:6/22/2010

Karolinska Institutet has received a grant of SEK 100 million from the Knut and Alice Wallenberg Foundation for a regenerative medicine research centre the Wallenberg Institute for Regenerative Medicine (WIRM). This funding will give Karolinska Institutet a unique opportunity to concentrate on new and pioneering research, with a special focus on the blood system.

Regenerative research and stem-cell research are two areas in which revolutionary scientific advances have been made in recent years. The Swedish medical university Karolinska Institutet has long held a leading international position in these rapidly developing fields.

"The establishment of WIRM represents a unique opportunity to bring Karolinska Institutet's internationally leading basic research and clinical research together at a completely new centre. It will make it possible to address research issues we currently lack the resources to tackle," says Professor Urban Lendahl, Scientific Director of WIRM.

Growing knowledge of stem cells and regenerative medicine has opened up completely new avenues for the treatment of a number of diseases. The research at WIRM will cover a broad range of areas of therapy, but will focus in particular on the blood system and on the continued development of bone-marrow transplantation for those medical conditions and groups of patients that cannot currently be treated.

"It's tremendously pleasing and flattering that the bicentenary of Karolinska Institutet is being marked with this generous research grant from the Knut and Alice Wallenberg Foundation. The grant opens up fantastic opportunities for us to pursue pioneering research at the very highest international level in these extremely important areas," says Professor Harriet Wallberg-Henriksson, the President of Karolinska Institutet.

Thanks to the grant from the Wallenberg Foundation and the new research centre, Karolinska Institutet's infrastructure in the area is being strengthened through the establishment of advanced technical equipment and new experimental techniques. It is of the greatest strategic significance that the grant makes it possible to recruit key expertise, which will be crucially important in further advancing Sweden's position in this area.

"Having the opportunity to conduct research at Karolinska Institutet is a tremendously attractive prospect. The newly opened WIRM research centre will be well-placed to further strengthen the internationally leading position of Karolinska Institutet in stem-cell research and regenerative medicine," says Professor Sten Erik W. Jacobsen, a world-leading researcher at Oxford University in the biology and diseases of the blood system, who will now pursue part of his research in collaboration with investigators at Karolinska Institutet and WIRM.


'/>"/>

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. Kaiser Permanente Gives $5 Million to Childrens Healthcare of Atlanta
2. RadioShack Customers Donate $1.3 Million to LIVESTRONG
3. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
4. Human Rights Denied: Obama Leaves 75 Million Children Behind
5. NVHR: Administrations 2011 Budget Proposal Shortchanges Five Million Americans Afflicted with Chronic Viral Hepatitis
6. State $200 Million Behind in Payments to Agencies Providing Care to Thousands of Older Illinoisans
7. Prominent Beverly Hills Law Firm Awarded $16.5 Million Medical Malpractice Jury Verdict
8. Esperanza Health Center Receives $6.5 Million in Stimulus Funds
9. Fitch, Standard & Poor's Upgrade Scripps Health to AA-; Scripps to Issue $220 Million in Hospital Revenue Bonds
10. millionants productions Launches and is “Making a Scene”
11. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Aerolib Healthcare Solutions ... Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization Review ... of Disease Specific Documentation Improvement. , The Aerolib Learning Management System is ...
(Date:1/19/2017)... ... 19, 2017 , ... With the cold weather here, many people will have to clear snow ... clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s why ... Commission for the proper use of snow blowers:, , When removing ...
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital media company ... Heart Association (AHA) to produce a three-part video series that uses humor to highlight ... of the launch of AHA’s Healthy For Good™ movement, which is designed to inspire ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is ... year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday ... clinic’s leading recovery program. , “We know it’s easy to get carried ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... recently provided a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health ... facility were used to facilitate a recapitalization of MedPro led by Harren Equity ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... 19, 2017 While various ... about reducing the FDA,s regulatory strictness as a ... medical drug industry, many of the leading biotech ... trials and development of advanced drug treatments and ... recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: